BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1914 related articles for article (PubMed ID: 18237800)

  • 1. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
    Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy.
    Bush DA; Slater JD; Garberoglio C; Yuh G; Hocko JM; Slater JM
    Cancer J; 2007; 13(2):114-8. PubMed ID: 17476139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
    Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
    Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.
    Suit H; DeLaney T; Goldberg S; Paganetti H; Clasie B; Gerweck L; Niemierko A; Hall E; Flanz J; Hallman J; Trofimov A
    Radiother Oncol; 2010 Apr; 95(1):3-22. PubMed ID: 20185186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beams to replace photon beams in radical dose treatments.
    Suit H; Goldberg S; Niemierko A; Trofimov A; Adams J; Paganetti H; Chen GT; Bortfeld T; Rosenthal S; Loeffler J; Delaney T
    Acta Oncol; 2003; 42(8):800-8. PubMed ID: 14968940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of proton beams in radiation oncology.
    Loeffler JS; Smith AR; Suit HD
    Semin Oncol; 1997 Dec; 24(6):686-95. PubMed ID: 9422264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New technologies in radiation therapy for pediatric brain tumors: the rationale for proton radiation therapy.
    Kirsch DG; Tarbell NJ
    Pediatr Blood Cancer; 2004 May; 42(5):461-4. PubMed ID: 15049021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary neutrons in clinical proton radiotherapy: a charged issue.
    Brenner DJ; Hall EJ
    Radiother Oncol; 2008 Feb; 86(2):165-70. PubMed ID: 18192046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
    Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
    Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
    Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical controversies: proton radiation therapy for brain and skull base tumors.
    Combs SE; Laperriere N; Brada M
    Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy systems using proton and carbon beams.
    Jongen Y
    Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 96.